Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesCushing disease as possible cause of persistent growth failure despite growth hormone therapy in a small for gestational age male
Pituitary, 09/25/09
Heneghan M et al. – The authors report the case of an 11–year–old Caucasian male who developed early adrenarche, hypertension and insulin resistance on GH therapy for SGA and profound short stature. The patient’s diagnosis of Cushing’s disease was complicated by his past history of poor growth since birth and history of SGA. The signs of Cushing’s disease did not overtly appear until GH therapy was initiated to help treat severe short stature. It is possible that the metabolic effects of GH therapy unmasked the presence of underlying Cushing’s disease.
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Regulation of lipid metabolism by energy availability: a role for the central nervous system
Obesity Reviews, 11/06/09
Sponsor
Article Search
Sponsor